We analyze the laboratories that are going to launch their respective vaccines throughout (except for delays) in 2021. Some action is more interesting than others but in most we see a clear technical aspect with an upward trend that can continue with the exit of their serums.
The order of analysis is as follows: SANOFI y GLAXOSMITHKLINE (GSK) that can ship their products later this year. Something closer in time and with their respective delays, they are NOVAVAX, CUREVAC y VALNEVA. In the video we mark the technical levels and most relevant structures of these actions that will soon be on everyone’s lips.